Related Experiment Videos
Enzyme activities in human breast tumours
1Department of Cell Biology, University of Maria Curie-Skłodowska, Lublin, Poland.
Acta Biochimica Polonica
|January 1, 1992
Summary
Breast cancer tissues exhibit altered carbohydrate metabolism enzyme activity compared to normal tissues. Key enzyme ratios differ, indicating metabolic pathway shifts, particularly between early and advanced disease stages.
Area of Science:
- Biochemistry
- Oncology
- Metabolic research
Background:
- Carbohydrate metabolism plays a crucial role in cellular energy production and biosynthesis.
- Alterations in metabolic pathways are a hallmark of cancer, including breast cancer.
- Understanding enzyme activity differences can provide insights into tumor progression.
Purpose of the Study:
- To investigate the activity levels of six key carbohydrate metabolism enzymes in breast carcinomas versus normal breast tissues.
- To analyze the ratios of specific enzymes (glutamate dehydrogenase, hydroxybutyrate dehydrogenase, glutathione reductase, catalase) relative to lactate dehydrogenase and glucose-6-phosphate dehydrogenase in cancerous and normal tissues.
- To examine enzyme activity differences across various stages of breast cancer, including metastatic tissues.
Main Methods:
- Enzyme activity assays were performed on both human breast carcinoma and adjacent normal tissue samples.
- Quantitative measurements of six enzymes involved in carbohydrate metabolism were conducted.
- Comparative analysis of enzyme activities and specific enzyme ratios between normal and cancerous tissues was performed.
- Statistical analysis was used to compare enzyme profiles across different clinical stages (I, II, III) and metastatic samples.
Main Results:
- Breast carcinomas demonstrated higher overall activity for the measured carbohydrate metabolism enzymes compared to normal breast tissue.
- Ratios of glutamate dehydrogenase, hydroxybutyrate dehydrogenase, glutathione reductase, and catalase to lactate dehydrogenase were significantly lower in carcinomas.
- Similar significant reductions in these enzyme ratios were observed when compared to glucose-6-phosphate dehydrogenase in carcinomas.
- No significant enzyme activity differences were found between Stage I and II disease or metastatic tissues, but significant differences existed between Stage I and III.
Conclusions:
- The observed changes in enzyme activities and ratios suggest a significant alteration in carbohydrate metabolic pathways in breast cancer.
- These metabolic shifts may contribute to tumor growth and progression.
- The differential enzyme profiles across disease stages highlight potential biomarkers for monitoring breast cancer advancement.